For years, obstructive sleep apnea in pregnant patients has been managed largely by borrowing rules written for everyone else. A new clinical practice guideline from the American College of Chest Physicians (CHEST) aims to close that gap, offering the first dedicated, evidence-based roadmap for screening, diagnosing, treating, and following up on sleep-disordered breathing during pregnancy.
The guideline, published in the journal CHEST and led by Carolyn D'Ambrosio, MD, FCCP, lays out nine conditional recommendations. All nine carry a "very low" certainty-of-evidence rating — a reflection of how little pregnancy-specific research has existed until now, and exactly the gap the guideline is meant to start closing.
Why Pregnancy Changes the Calculus
Sleep apnea risk rises during pregnancy for reasons that have nothing to do with the usual risk factors doctors screen for. Weight gain, fluid retention, hormonal shifts, and changes in upper airway tissue can all narrow the airway or increase collapsibility during sleep, even in patients with no prior history of the condition.
The stakes are higher, too. According to the guideline, measures of sleep-disordered breathing during pregnancy have been associated with adverse fetal growth outcomes, higher rates of neonatal intensive care unit admission, longer hospital stays, congenital anomalies, and preterm birth. Sleep apnea in pregnancy has also been linked in prior research to gestational hypertension, preeclampsia, and gestational diabetes.
What the Guideline Actually Recommends
The nine recommendations focus on standardizing decisions that, until now, varied widely by provider and institution:
- Screen pregnant patients for sleep-disordered breathing symptoms, rather than waiting for a patient to raise concerns unprompted.
- Diagnose and treat based on severity thresholds tailored to pregnancy — specifically an apnea-hypopnea index (AHI) of 5 to 15 when symptoms, other health effects, or relevant comorbidities are present, or an AHI above 15 on its own, regardless of symptoms.
- Treat with CPAP as the first-line therapy, matching the standard of care outside pregnancy.
- Recommend the same behavioral modifications used in non-pregnant patients with OSA — avoiding sedatives, smoking, and alcohol — while explicitly declining to recommend weight loss during pregnancy, given the potential for harm to the fetus.
- Reassess patients after delivery. The guideline calls for considering repeat diagnostic testing in the postpartum period, noting that while AHI tends to improve after birth, small studies have found that sleep apnea persists in nearly half of patients who were diagnosed with it during pregnancy.
A Narrow Evidence Base, by Design
The guideline panel was explicit that the "very low" certainty rating on every recommendation reflects the current state of the research, not weak reasoning. Randomized controlled trials of OSA screening and treatment specifically in pregnant populations remain scarce, and most of the existing evidence is extrapolated from cohort studies or from non-pregnant populations. The panel's approach was to formalize the best available practice now, while flagging exactly where future trials are needed most — screening thresholds, postpartum testing intervals, and whether treating milder cases changes maternal or fetal outcomes.
That structure matters for a condition that has historically been underdiagnosed in pregnant patients, in part because fatigue, snoring, and disrupted sleep are so often dismissed as ordinary features of pregnancy rather than signs of a treatable disorder.
What This Means for Patients
Pregnant patients experiencing loud snoring, witnessed pauses in breathing during sleep, or persistent excessive daytime fatigue now have a clearer clinical pathway to raise with their obstetric provider, rather than a symptom likely to be waved off as normal pregnancy exhaustion. The guideline gives clinicians specific AHI thresholds for when to treat, confirms CPAP as the preferred therapy, and — notably — builds in a postpartum check that many patients previously fell through the cracks of, given that sleep apnea diagnosed in pregnancy frequently does not resolve on its own after delivery. Patients with risk factors such as obesity, chronic hypertension, or a prior pregnancy complicated by preeclampsia or gestational diabetes may be reasonable candidates to discuss screening with their provider even in the absence of classic OSA symptoms.
